CSL Behring Austria today announced that the first haemophilia B patient in Austria was treated with the gene therapy HEMGENIX® (etranacogene dezaparvovec) at the Comprehensive Care Center of the ...

The primary objective was therefore to establish if there is an improvement in survival at 30 days with the use of WB transfusion compared with blood component therapy in adult trauma patients with ...

The volume contains a practical worksheet for preliminary screening of capacities ... The ABA/APA Assessment of Capacity in Older Adults Project Working Group convened in 2003 and jointly published ...

The study also stressed that hormone therapy was integrated into each patient ... person’s gender-affirming primary healthcare. TGD adults are two to four times more likely than cisgender ...